Canada Complex Regional Pain Syndrome (CRPS) Market Report 2023 to 2030

Canada Complex Regional Pain Syndrome (CRPS) Market Analysis

$ 3999

Canada Complex regional pain syndrome (CRPS) Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Complex regional pain syndrome (CRPS) is expanding as a result of rising incidence of complex regional pain syndrome and the growing number of patients suffering from chronic pain and failing back syndrome. Growth in R&D spending by both commercial and public institutions, as well as favourable government legislation and increase in product launches are other factors increasing market growth. Ovid therapeutics, Astra Zeneca, Abbott, GSK, Viatris and Johnson & Johnson Services are the top key market players in Global Complex regional pain syndrome (CRPS) market.

ID: IN10CARD078 CATEGORY: Rare Diseases GEOGRAPHY: Canada AUTHOR: Gaurav Bhongale

Buy Now

Canada Complex Regional Pain Syndrome (CRPS) Market Analysis Summary

Canada Complex Regional Pain Syndrome (CRPS) Market is valued at around $8.08 Mn in 2022 and is projected to reach $9.62 Mn by 2030, exhibiting a CAGR of 2.2% during the forecast period 2023-2030.

The Complex regional pain syndrome (CRPS) market includes all the drugs and therapies which are used to treat and manage Complex regional pain syndrome (CRPS). The painful condition known as complex regional pain syndrome (CRPS), commonly referred to as Sudecks dystrophy or reflex sympathetic dystrophy is a rare debilitating disorder characterized by severe and persisting pain affecting one or more limbs. Its symptoms are pain, sensory, Sudo- and vasomotor abnormalities, trophic alterations, and reduced motor function. Due to the complexity and wide range of symptoms, CRPS patients are treated by doctors with a variety of clinical backgrounds, including anesthesiologists, (orthopaedic) surgeons, neurologists, rheumatologists, and rehabilitation centres. There are no approved drugs to treat Complex Regional Pain Syndrome. On the other side, doctors suggest therapy and drugs to treat ad manage chronic pain. Spinal cord stimulation is one such therapy.

Market Dynamics

Market Drivers

Rising Incidence and prevalence – Rising incidence and prevalence of Complex regional pain syndrome (CRPS) patients and patients suffering from chronic pain. This results in a sizable patient population in need of efficient therapies which drives the market.

An increase in product launches is going to further drive the market

Intense research and development funding by both private and public organizations and a growing number of non-profit initiatives are market drivers.

Various government initiatives to raise awareness about the syndrome and chronic pain are expected to drive market growth during the forecast period.

The spinal cord stimulation segment is also expected to act as a market driver over the forecast period- An implanted device called a spinal cord stimulator delivers low-voltage electricity to the spinal cord to relieve pain. A spinal cord stimulator can effectively and safely treat CRPS pain because the condition involves severe chronic pain, and it has few to no negative side effects.

Market Restraints

Tight regulatory approval and high medicine costs act as market restraints of the Complex regional pain syndrome (CRPS) market.

Lack of in-depth knowledge and research in CRPS, Shortage of medical and behavioural CRPS physicians and professionals treating syndrome are also market growth restraints.

Lack of effective treatment choices and lack of awareness globally about the syndrome are also market growth restraints.

Key players

Eli Lilly and Co Novartis AG Pfizer Inc Roche Holding AG Sanofi Acorda Therapeutics Inc Catalyst Biosciences Inc Ipsen SA Jazz Pharmaceuticals plc Zogenix Inc

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For Canada Complex regional pain syndrome (CRPS) market

By Therapy:

Physical Therapy
Therapy via Drugs

Analgesics
Antidepressants
Corticosteroids

Spinal Cord Stimulation
Surgical Sympathectomy
Intrathecal Drug Pumps

By Route of Administration:

Oral therapy
Intravenous therapy

By Distribution Channel:

Hospital Pharmacy
Drug stores
Retail Pharmacy
E-commerce

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.